Ketamine‐An Update on Its Clinical Uses and Abuses

The Drug Enforcement Administration (DEA) classified ketamine as a Schedule III drug. This drug can change people’s sensory perceptions. People who use ketamine recreationally are at risk of serious, immediate consequences.

Dopamine D1 Receptors

Acute inhibition of the lateral habenula, a part of the brain responsible for inhibiting the mesolimbic reward pathway and referred to as the “anti-reward center”, is another possible mechanism for ketamine’s antidepressant effects. This furthers the argument that NMDA receptor antagonism may not be primarily responsible for the antidepressant effects of ketamine. Due to the hypothesis that NMDA receptor antagonism underlies the antidepressant effects of ketamine, esketamine was developed as an antidepressant. Blocking of the NMDA receptor results in analgesia by preventing central sensitization in dorsal horn neurons; in other words, ketamine’s actions interfere with pain transmission in the spinal cord.

The biliary dilation and subsequent cholestasis usually mimic the symptoms of obstructive jaundice in the absence of an obstructing lesion 85. In the following chapter, we will discuss these severe problems related to its abuse in detail. Combination opioid with ketamine could significantly decrease the dose of opioid in certain surgeries and thus cause less respiratory problems in children sensitive to opioid.

Behavioral Symptoms of Ketamine Usage and Abuse

Conjugated hydroxylated derivatives of ketamine (80%) followed by dehydronorketamine (16%) are the most prevalent metabolites detected in urine. After an intravenous injection of tritium-labelled ketamine, 91% of the radioactivity is recovered from urine and 3% from feces. This also explains why oral ketamine levels are independent of CYP2B6 activity, unlike subcutaneous ketamine levels. As a result, norketamine plasma levels are several-fold higher than ketamine following oral administration, and norketamine may play a role in anesthetic and analgesic action of oral ketamine.

There’s an increasing prevalence of non-medical ketamine abuse in some regions and among certain demographics. One case report suggested a glutamate release inhibitor called Lamotrigine to reduce ketamine cravings and depression, which are the most common problems reported by chronic ketamine users. In 2000, Yale’s Dr. John Krystal and colleagues demonstrated that low-dose, intravenous racemic ketamine produced rapid, significant antidepressant effects in patients with treatment-resistant depression.

In relatively recent years, ketamine has gained popularity as a “club drug” used by teenagers and young adults at raves or parties.3 A national survey of American youth in 2023, estimated that nearly 1% of all high school seniors had used ketamine in the past year.4 A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. In summary, the current literature supports the use of ketamine in carefully controlled medical environments, where its benefits can be maximized and its risks mitigated. While the benefits of ketamine in clinical settings are well-documented, the broader narrative of celebrity drug use remains mired in uncertainty and sensationalism. The media reports linking Elon Musk to ketamine—and other drug use—illustrate the challenges of separating verified scientific fact from speculative commentary.

For the most part, ketamine had been viewed warily by mainstream scientists. It has been around for decades, enjoying a boom as a party drug in the ’80s and ’90s. People should not try to self-medicate with ketamine, Yang said. But the drug does coexist as a therapeutic and a narcotic, and the line between the two can be blurry.

  • We performed a systematic review of studies reporting functional and structural brain changes after repeated ketamine abuse.
  • Ketamine’s profile as a rapid-acting antidepressant has revolutionized approaches to treatment-resistant depression.
  • We included 16 studies in our review, totaling 440 chronic ketamine users with a mean ketamine use of 2–9.7 years and 2.4 grams per day, compared to 259 drug-free controls and 44 poly-drug controls.
  • Young people presenting with depression, memory loss, or frequent urinary complaints should be screened for drug misuse, including ketamine, before delving into further diagnostic matters.
  • The bronchodilator ketamine mediated the relax of tracheal smooth muscle by blocking the NMDA receptor 68.
  • In vivo, ketamine rapidly activates the mTOR pathway, promoting synaptogenesis and reversing stress-related synaptic deficits in the prefrontal cortex, which might underlie its fast-acting antidepressant effects in treatment-resistant depression.
  • These investigations demonstrated ketamine’s short duration of action and reduced behavioral toxicity made it a favorable choice over phencyclidine (PCP) as an anesthetic.

These effects did not persist beyond one week, although a higher dropout rate in some studies means that the benefit duration remains unclear. The antidepressant carisoprodol drug information effect of ketamine is diminished at 7 days, and most people relapse within 10 days. Although only a few pilot studies have sought to determine the optimal dose, increasing evidence suggests that 0.5 mg/kg dose injected over 40 minutes gives an optimal outcome. In particular, only for CRPS, there is evidence of medium to longer-term pain relief.

Studies indicate that ketamine-induced cystitis is caused by ketamine and its metabolites directly interacting with urothelium, demi moore sober resulting in damage of the epithelial cells of the bladder lining and increased permeability of the urothelial barrier which results in clinical symptoms. Vomiting can be expected in 5–15% of the patients; pretreatment with propofol mitigates it as well. Psychotomimetic effects decrease when adding lamotrigine and nimodipine and can be counteracted by pretreatment with a benzodiazepine or propofol.

What Are the Signs of Ketamine Addiction?

Perry, 54, began seeking more ketamine than his doctor would give him. Actor Matthew Perry was addicted to intravenous ketamine when he overdosed and died in 2023, reminding us that ketamine is dangerous and too accessible. It can lead to addiction and dependence if you use it frequently. You can suffer from accidents, overdose, or hurt other people during this time.

Mechanism of action

The mechanisms of ketamine effects are mainly related to its inhibition to NMDA receptor pathway. Ketamine is an example cotton fever symptoms of how an existing drug can be readapted for multiple uses including treatment of depression and asthmaticus. A retrospective study demonstrated that in patients with ketamine‐induced uropathy, 44.4% were diagnosed with hydronephrosis 92. In a cross‐sectional survey of 297 consecutive chronic abusers, the prevalence of liver injury was 9.8% and all cases are cholestatic related 86. Using ketamine preemptively as an analgesic adjuvant has shown the effects on postoperative pain.

  • Also, they found a correlation between higher sgACC connectivity with the dmPFC and higher depression scores in women, but not in men.
  • If you’re looking to quit ketamine, make sure you listen to your doctor’s instructions for getting off it.
  • Long-term ketamine use can cause significant health issues, such as problems with the bladder and other internal organs.
  • Due to its properties, the potential for misuse of ketamine was already there from its inception and contributed to its diversion.
  • The K-hole experience may cause people to behave recklessly and get into dangerous situations.
  • However, the dose‐ and duration‐related side effects of ketamine are usually reported, such as psychotomimetic effects, increases in blood pressure and heart rate 19, 20.

However, studies conducted in abdominal hysterectomy and open colorectal surgery did not confirm such relief 76, 77. Activation of N‐methyl‐D‐aspartate (NMDA) receptor played an important role in the development of perioperative nociception‐related neural sensitization, hypersensitivity, and opioid tolerance 73, 74. It has been shown that increase in free norepinephrine parallels the peak bronchodilatory effect of ketamine, and this effect can be diminished by β‐adrenergic blockade. These endogenous catecholamines act on β2 receptors and lead to bronchodilation.

This may suggest that ReHo is initially increased more by ketamine use but that this increase eventually decreases with more prolonged and intensive use, which may alter functional organization in frontal networks. The higher ReHo in the left precentral frontal gyrus was negatively correlated with estimated total lifetime ketamine consumption and ketamine craving (Liao et al., 2012). Functional connectivity between the posterior parietal cortex and right lateral dorsal nucleus was significantly correlated to individual ketamine craving scores (Liao et al., 2016). Opposingly, one could hypothesize that increased white matter volume may imply that an underlying low grade inflammatory edematous process exists, comparable to edema observed after brain injury (Weimer et al., 2017). Axial diffusivity was significantly lower in eight white matter clusters in the right hemisphere in the ketamine group compared to the control group, the three largest being located in the frontal cortex (Edward Roberts et al., 2014).

What are Ketamine Addiction Treatment Options?

The most common psychiatric side effects are dissociation, visual distortions, and numbness. Ketamine, generally, stimulates breathing; however, in the first 2–3 minutes of a high-dose rapid intravenous injection, it may cause a transient respiratory depression. Ketamine anesthesia commonly causes tonic-clonic movements (greater than 10% of people) and rarely hypertonia. At anesthetic doses, 10–20% of adults and 1–2% of children experience adverse psychiatric reactions that occur during emergence from anesthesia, ranging from dreams and dysphoria to hallucinations and emergence delirium.